Immunome (IMNM) Enterprise Value (2019 - 2026)
Immunome (IMNM) posted Enterprise Value of -$582.7 million for Q1 2026, up 10.83% on a QoQ basis from -$653.5 million in Q4 2025, and down 83.63% year-over-year from -$3.6 billion in Q1 2025.
Immunome (IMNM) Enterprise Value (2019 - 2026) Analysis & Trends
Immunome's Enterprise Value history runs 8 years deep, the most recent figure standing at -$582.7 million for Q1 2026.
- Quarterly Enterprise Value fell 83.63% year-over-year to -$582.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$582.7 million (down 83.63% YoY) and the FY2025 annual result came in at -$653.5 million, down 200.72% from the prior year.
- Enterprise Value was -$582.7 million for Q1 2026 at Immunome, up from -$653.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$20.3 million in Q4 2022 and bottomed at -$653.5 million in Q4 2025.
- A 5-year average of -$210.4 million and a median of -$217.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 58.72% — and 2024, when it tumbled 624.52%.
- Immunome's Enterprise Value stood at -$20.3 million in 2022, then sank by 579.73% to -$138.1 million in 2023, then sank by 57.3% to -$217.3 million in 2024, then slumped by 200.72% to -$653.5 million in 2025, then climbed by 10.83% to -$582.7 million in 2026.
- Business Quant data shows IMNM's Enterprise Value at -$582.7 million in Q1 2026, -$653.5 million in Q4 2025, and -$272.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - | -582.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -582.69 Mn |
| Dec 31, 2025 | -653.48 Mn |
| Sep 30, 2025 | -272.64 Mn |
| Jun 30, 2025 | -268.10 Mn |
| Mar 31, 2025 | -317.31 Mn |
| Dec 31, 2024 | -217.30 Mn |
| Sep 30, 2024 | -240.13 Mn |
| Jun 30, 2024 | -278.33 Mn |
| Mar 31, 2024 | -309.71 Mn |
| Dec 31, 2023 | -138.14 Mn |
| Sep 30, 2023 | -90.64 Mn |
| Jun 30, 2023 | -38.42 Mn |
| Mar 31, 2023 | -44.42 Mn |
| Dec 31, 2022 | -20.32 Mn |
| Sep 30, 2022 | -27.08 Mn |
| Jun 30, 2022 | -34.65 Mn |
| Mar 31, 2022 | -42.88 Mn |
| Dec 31, 2021 | -49.23 Mn |
| Sep 30, 2021 | -56.24 Mn |
| Jun 30, 2021 | -59.83 Mn |